In one study, PON1 activities were found to be significantly decreased (Table 1) while PAF-AH activity and oxLDL levels were significantly increased in 49 AD patients (74 years old, 59% female, MMSE score = 21 ± 5) compared to 34 age/sex-matched control individuals [63]. This evidence concerns the gene PON1 and Alzheimer disease.